prof. MUDr. Boris Mravec, PhD.
Vedecko/umelecko-pedagogická charakteristika:
Najvýznamnejšie výstupy tvorivej činnosti: VTC1, VTC2, VTC3, VTC4, VTC5
1. | Mravec B. Neurobiology of cancer: Introduction of new drugs in the treatment and prevention of cancer. International journal of molecular sciences. 2021 | Q1 | IF 5,924 |
2. | Mravec B, Horvathova L, Hunakova L. Neurobiology of cancer: the role of β-adrenergic receptor signaling in various tumor environments. International journal of molecular sciences. 2020 | Q1 | IF 5,924 |
3. | Mravec B, Lejavova K, Vargovic P, Ondicova K, Horvathova L, Novak P, Manz G, Filipcik P, Novak M, Kvetnansky R. Tauopathy in transgenic (SHR72) rats impairs function of central noradrenergic system and promotes neuroinflammation. J Neuroinflammation. 2016 | Q1 | IF 5,102 |
4. | Altaner C, Altanerova V, Cihova M, Ondicova K, Rychly B, Baciak L, Mravec B. Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario. International Journal of Cancer. 2014 | Q1 | IF 5,085 |
5. | Ondicova K, Mravec B. Role of nervous system in cancer aetiopathogenesis. Lancet Oncology. 2010 | Q1 | IF 17,764 |